Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on November 15, 2023. The filing serves to incorporate by reference a press release (Exhibit 99.1) dated November 15, 2023, into the company's existing registration statements on Forms F-3 and S-8.
Financial Metrics
The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing acts solely as a conduit for the referenced press release.
Material Changes
The filing text does not disclose specific material changes versus prior periods. It only confirms the incorporation of the November 15, 2023, press release by reference.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the text of this Form 6-K. These details are contained within the referenced Exhibit 99.1 (Press Release), which is not included in the input content.
Key Facts for Investor Verification
- Verify the content of the Press Release dated November 15, 2023 (Exhibit 99.1), as the Form 6-K itself contains no substantive operational or financial data.
- Confirm the impact of the referenced press release on the company's active registration statements (Forms F-3 and S-8).
- Note that the filing was signed by André Choulika, Chief Executive Officer.